Growth Metrics

Mannkind (MNKD) EPS (Basic) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 -266.67%
Sep 30, 2025 1,266.27%
Jun 30, 2025 -94.51%
Mar 31, 2025 33.33%
Dec 31, 2024 -25.00%
Sep 30, 2024 500.00%
Jun 30, 2024 -125.00%
Mar 31, 2024 300.00%
Dec 31, 2023 0.00%
Sep 30, 2023 150.00%
Jun 30, 2023 50.00%
Mar 31, 2023 42.86%
Dec 31, 2022 -16.67%
Sep 30, 2022 45.45%
Jun 30, 2022 -10.00%
Mar 31, 2022 9.09%
Dec 31, 2021 -450.00%
Sep 30, 2021 85.71%
Jun 30, 2021 -180.00%
Mar 31, 2021 58.33%
Dec 31, 2020 -140.00%
Sep 30, 2020 0.00%
Jun 30, 2020 -25.00%
Mar 31, 2020 42.86%
Dec 31, 2019 -40.00%
Sep 30, 2019 28.57%
Jun 30, 2019 12.50%
Mar 31, 2019 -33.33%
Dec 31, 2018 62.50%
Sep 30, 2018 0.00%
Jun 30, 2018 36.00%
Mar 31, 2018 10.71%
Dec 31, 2017 9.68%
Sep 30, 2017 11.43%
Jun 30, 2017 -105.88%
Mar 31, 2017 -130.36%
Dec 31, 2016 -57.58%
Sep 30, 2016 500.00%
Jun 30, 2016 -13.79%
Mar 31, 2016 56.06%
Dec 31, 2015 -69.23%
Sep 30, 2015 -8.33%
Jun 30, 2015 -350.00%
Mar 31, 2015 11.11%
Dec 31, 2014 0.00%
Sep 30, 2014 52.63%
Jun 30, 2014 -35.71%
Mar 31, 2014 12.50%
Dec 31, 2013 5.88%
Sep 30, 2013 -6.25%
Jun 30, 2013 -6.67%
Mar 31, 2013 34.78%
Dec 31, 2012 -4.55%
Sep 30, 2012 4.35%
Jun 30, 2012 14.81%
Mar 31, 2012 10.00%
Dec 31, 2011 3.23%
Sep 30, 2011 16.22%
Jun 30, 2011 -8.82%
Mar 31, 2011 -3.03%
Dec 31, 2010 17.50%
Sep 30, 2010 -8.11%